These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 15300675)
81. Therapeutic use of medical Cannabis in neurological diseases: a clinical update. Hidding U; Mainka T; Buhmann C J Neural Transm (Vienna); 2024 Feb; 131(2):117-126. PubMed ID: 38015317 [TBL] [Abstract][Full Text] [Related]
82. Cannabinoids and dystonia: an issue yet to be defined. Mascia MM; Carmagnini D; Defazio G Neurol Sci; 2020 Apr; 41(4):783-787. PubMed ID: 31848779 [TBL] [Abstract][Full Text] [Related]
83. Consensus paper: Decoding the Contributions of the Cerebellum as a Time Machine. From Neurons to Clinical Applications. Bareš M; Apps R; Avanzino L; Breska A; D'Angelo E; Filip P; Gerwig M; Ivry RB; Lawrenson CL; Louis ED; Lusk NA; Manto M; Meck WH; Mitoma H; Petter EA Cerebellum; 2019 Apr; 18(2):266-286. PubMed ID: 30259343 [TBL] [Abstract][Full Text] [Related]
84. Association between gene polymorphisms and obesity and physical fitness in Korean children. Kim HJ; Lee SY; Kim CM Biol Sport; 2018 Mar; 35(1):21-27. PubMed ID: 30237658 [TBL] [Abstract][Full Text] [Related]
85. Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3. Rodríguez-Cueto C; Hernández-Gálvez M; Hillard CJ; Maciel P; Valdeolivas S; Ramos JA; Gómez-Ruiz M; Fernández-Ruiz J PLoS One; 2017; 12(4):e0176521. PubMed ID: 28448548 [TBL] [Abstract][Full Text] [Related]
86. Time Processing and Motor Control in Movement Disorders. Avanzino L; Pelosin E; Vicario CM; Lagravinese G; Abbruzzese G; Martino D Front Hum Neurosci; 2016; 10():631. PubMed ID: 28018198 [TBL] [Abstract][Full Text] [Related]
88. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia. García C; Palomo-Garo C; Gómez-Gálvez Y; Fernández-Ruiz J Br J Pharmacol; 2016 Jul; 173(13):2069-79. PubMed ID: 26059564 [TBL] [Abstract][Full Text] [Related]
89. Focal Task-specific Dystonia-From Early Descriptions to a New, Modern Formulation. Frucht SJ Tremor Other Hyperkinet Mov (N Y); 2014; 4():230. PubMed ID: 24757587 [TBL] [Abstract][Full Text] [Related]
90. Rating scales for musician's dystonia: the state of the art. Peterson DA; Berque P; Jabusch HC; Altenmüller E; Frucht SJ Neurology; 2013 Aug; 81(6):589-98. PubMed ID: 23884039 [TBL] [Abstract][Full Text] [Related]
91. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders. Fernández-Ruiz J; Hernández M; Ramos JA CNS Neurosci Ther; 2010 Jun; 16(3):e72-91. PubMed ID: 20406253 [TBL] [Abstract][Full Text] [Related]
92. Cannabinoids in health and disease. Kogan NM; Mechoulam R Dialogues Clin Neurosci; 2007; 9(4):413-30. PubMed ID: 18286801 [TBL] [Abstract][Full Text] [Related]
93. The endocannabinoid system as an emerging target of pharmacotherapy. Pacher P; Bátkai S; Kunos G Pharmacol Rev; 2006 Sep; 58(3):389-462. PubMed ID: 16968947 [TBL] [Abstract][Full Text] [Related]
96. Bach, botox, and butterflies: toward an awareness of musician's dystonia. Passero MA Med Health R I; 2007 Aug; 90(8):238-9. PubMed ID: 17867407 [No Abstract] [Full Text] [Related]
97. Failure of cathodal direct current stimulation to improve fine motor control in musician's dystonia. Buttkus F; Weidenmüller M; Schneider S; Jabusch HC; Nitsche MA; Paulus W; Altenmüller E Mov Disord; 2010 Feb; 25(3):389-94. PubMed ID: 20063390 [TBL] [Abstract][Full Text] [Related]
98. Focal hand dystonia in musicians: phenomenology, etiology, and psychological trigger factors. Altenmüller E; Jabusch HC J Hand Ther; 2009; 22(2):144-54; quiz 155. PubMed ID: 19278826 [TBL] [Abstract][Full Text] [Related]
99. Delta9-tetrahydrocannabinol improves motor control in a patient with musician's dystonia. Jabusch HC; Schneider U; Altenmüller E Mov Disord; 2004 Aug; 19(8):990-1. PubMed ID: 15300675 [No Abstract] [Full Text] [Related]